319 related articles for article (PubMed ID: 17923423)
1. Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-alpha but not IL-1beta treatment at a post-transcriptional level in bovine cartilage explants.
Stevens AL; Wheeler CA; Tannenbaum SR; Grodzinsky AJ
Osteoarthritis Cartilage; 2008 Apr; 16(4):489-97. PubMed ID: 17923423
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha-dependent aggrecan cleavage and release of glycosaminoglycans in the meniscus is mediated by nitrous oxide-independent aggrecanase activity in vitro.
Voigt H; Lemke AK; Mentlein R; Schünke M; Kurz B
Arthritis Res Ther; 2009; 11(5):R141. PubMed ID: 19778432
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1alpha treatment of meniscal explants stimulates the production and release of aggrecanase-generated, GAG-substituted aggrecan products and also the release of pre-formed, aggrecanase-generated G1 and m-calpain-generated G1-G2.
Lemke AK; Sandy JD; Voigt H; Dreier R; Lee JH; Grodzinsky AJ; Mentlein R; Fay J; Schünke M; Kurz B
Cell Tissue Res; 2010 Apr; 340(1):179-88. PubMed ID: 20217136
[TBL] [Abstract][Full Text] [Related]
4. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
[TBL] [Abstract][Full Text] [Related]
5. Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2).
Chockalingam PS; Zeng W; Morris EA; Flannery CR
Arthritis Rheum; 2004 Sep; 50(9):2839-48. PubMed ID: 15457452
[TBL] [Abstract][Full Text] [Related]
6. Effects of glucosamine and chondroitin sulfate on bovine cartilage explants under long-term culture conditions.
Chan PS; Caron JP; Orth MW
Am J Vet Res; 2007 Jul; 68(7):709-15. PubMed ID: 17605605
[TBL] [Abstract][Full Text] [Related]
7. Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage.
Patwari P; Gao G; Lee JH; Grodzinsky AJ; Sandy JD
Osteoarthritis Cartilage; 2005 Apr; 13(4):269-77. PubMed ID: 15780640
[TBL] [Abstract][Full Text] [Related]
8. Aggrecanolysis and in vitro matrix degradation in the immature bovine meniscus: mechanisms and functional implications.
Wilson CG; Vanderploeg EJ; Zuo F; Sandy JD; Levenston ME
Arthritis Res Ther; 2009; 11(6):R173. PubMed ID: 19919704
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.
Sawaji Y; Hynes J; Vincent T; Saklatvala J
Arthritis Rheum; 2008 Nov; 58(11):3498-509. PubMed ID: 18975307
[TBL] [Abstract][Full Text] [Related]
10. Involvement of ADAMTS5 and hyaluronidase in aggrecan degradation and release from OSM-stimulated cartilage.
Durigova M; Troeberg L; Nagase H; Roughley PJ; Mort JS
Eur Cell Mater; 2011 Jan; 21():31-45. PubMed ID: 21225593
[TBL] [Abstract][Full Text] [Related]
11. Cyclin-dependent kinase 9 inhibition protects cartilage from the catabolic effects of proinflammatory cytokines.
Yik JH; Hu Z; Kumari R; Christiansen BA; Haudenschild DR
Arthritis Rheumatol; 2014 Jun; 66(6):1537-46. PubMed ID: 24470357
[TBL] [Abstract][Full Text] [Related]
12. Moderate dynamic compression inhibits pro-catabolic response of cartilage to mechanical injury, tumor necrosis factor-α and interleukin-6, but accentuates degradation above a strain threshold.
Li Y; Frank EH; Wang Y; Chubinskaya S; Huang HH; Grodzinsky AJ
Osteoarthritis Cartilage; 2013 Dec; 21(12):1933-41. PubMed ID: 24007885
[TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor alpha stimulates nitric oxide production more potently than interleukin-1beta in porcine articular chondrocytes.
Goodstone NJ; Hardingham TE
Rheumatology (Oxford); 2002 Aug; 41(8):883-91. PubMed ID: 12154205
[TBL] [Abstract][Full Text] [Related]
14. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.
Tortorella MD; Malfait AM; Deccico C; Arner E
Osteoarthritis Cartilage; 2001 Aug; 9(6):539-52. PubMed ID: 11520168
[TBL] [Abstract][Full Text] [Related]
15. Highly sulfated glycosaminoglycans inhibit aggrecanase degradation of aggrecan by bovine articular cartilage explant cultures.
Munteanu SE; Ilic MZ; Handley CJ
Matrix Biol; 2002 Aug; 21(5):429-40. PubMed ID: 12225808
[TBL] [Abstract][Full Text] [Related]
16. Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase-mediated cartilage degradation, but not aggrecanase-mediated cartilage degradation.
Karsdal MA; Sumer EU; Wulf H; Madsen SH; Christiansen C; Fosang AJ; Sondergaard BC
Arthritis Rheum; 2007 May; 56(5):1549-58. PubMed ID: 17469134
[TBL] [Abstract][Full Text] [Related]
17. MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein.
Durigova M; Nagase H; Mort JS; Roughley PJ
Matrix Biol; 2011 Mar; 30(2):145-53. PubMed ID: 21055468
[TBL] [Abstract][Full Text] [Related]
18. The effect of protease inhibitors on the induction of osteoarthritis-related biomarkers in bovine full-depth cartilage explants.
He Y; Zheng Q; Jiang M; Sun S; Christiansen TG; Kassem M; Karsdal MA; Bay-Jensen AC
PLoS One; 2015; 10(4):e0122700. PubMed ID: 25909781
[TBL] [Abstract][Full Text] [Related]
19. Brief Report: JNK-2 Controls Aggrecan Degradation in Murine Articular Cartilage and the Development of Experimental Osteoarthritis.
Ismail HM; Miotla-Zarebska J; Troeberg L; Tang X; Stott B; Yamamoto K; Nagase H; Fosang AJ; Vincent TL; Saklatvala J
Arthritis Rheumatol; 2016 May; 68(5):1165-71. PubMed ID: 26663140
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cartilage degradation and changes in physical properties induced by IL-1beta and retinoic acid using matrix metalloproteinase inhibitors.
Bonassar LJ; Sandy JD; Lark MW; Plaas AH; Frank EH; Grodzinsky AJ
Arch Biochem Biophys; 1997 Aug; 344(2):404-12. PubMed ID: 9264555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
